Article ID Journal Published Year Pages File Type
5536510 Vaccine 2017 7 Pages PDF
Abstract
This decentralised targeted HBV-vaccination program is a cost-effective intervention in certain unvaccinated high-risk adults. Saturation within the risk-groups, participation of individuals with less risky behaviour, and increased recruitment investments in the second period made the program less cost-effective over time. The project should therefore discus how to reduce costs per risk-group, increase effects or when to integrate the vaccination in regular healthcare.
Related Topics
Life Sciences Immunology and Microbiology Immunology
Authors
, , , , , , ,